Director of Endocrinology, Diabetes and Obesity Management Clinic University of Maryland Midtown Professionals
In this session, Dr. Haq will deliver current endocrine society guidelines on gender affirming therapies and the association of obesity with high dose reproductive hormone initiation.
Learning Objectives:
Recognize the pathways of transgender endocrine care management.
Describe the pathophysiology of metabolic syndrome in transgender patients
Utilize strategic management approaches to reduce obesity risk among transgender patients
Discuss the efficacy, safety and methods of choice in pharmacotherapy to manage obesity in transgender patient population
Apply non-pharmacological approaches in reducing obesity risk among transgender patient population
